Wordt geladen...
Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia‐inducible factor 1α axis
Inducing angiogenesis is a hallmark of cancers that sustains tumor growth and metastasis. Neovascularization is a surprisingly early event during the multistage progression of cancer. Cinobufagin, an important bufadienolide originating from Chan Su, has been clinically used to treat cancer in China...
Bewaard in:
| Gepubliceerd in: | Cancer Sci |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501006/ https://ncbi.nlm.nih.gov/pubmed/30839155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13988 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|